Logo of Capital Market Authority
The Capital Market Authority's (CMA) board approved, on Oct. 2, Al Mujtama Pharmacy's application for direct listing on Nomu-Parallel Market.
The offer will be confined to qualified investors stipulated in the glossary of defined terms used in the regulations and rules of the CMA. The prospectus will be published within sufficient time prior to the start of the offering.
The CMA's approval is valid for six months. It is deemed cancelled if the offering and listing are not completed within this period.
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}